First Light Asset Management, LLC - NGM BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
First Light Asset Management, LLC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$12,498,000
-14.2%
955,505
-15.9%
1.26%
-25.3%
Q2 2022$14,562,000
+16.9%
1,135,884
+39.1%
1.69%
+54.3%
Q1 2022$12,454,000
+23.2%
816,653
+43.0%
1.10%
+51.7%
Q4 2021$10,111,000570,8980.72%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$66,708,00043.30%
Ponoi II Management, LLC 1,298,908$23,004,00041.78%
Column Group LLC 15,396,116$272,665,00037.08%
Ponoi Management, LLC 1,298,908$23,004,00021.21%
Euclidean Capital LLC 746,674$13,224,0007.52%
StepStone Group LP 1,573,357$27,864,0001.59%
Logos Global Management LP 475,000$8,412,0000.87%
First Light Asset Management, LLC 570,898$10,111,0000.72%
BVF INC/IL 955,000$16,913,0000.61%
DAFNA Capital Management LLC 80,485$1,425,0000.36%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders